Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 50Completed 15Recruiting 3Not yet recruiting 3Terminated 2Suspended 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 2Non-small Cell Lung Cancer Metastatic 1

Interventions

pembrolizumab 563Specimen Handling 493Carboplatin 451Magnetic Resonance Spectroscopy 444Cyclophosphamide 418Cisplatin 405Radiotherapy 353Bevacizumab 314Gemcitabine 313Paclitaxel 298Biopsy 292Drug Therapy 284Blood Specimen Collection 248Capecitabine 246Oxaliplatin 241fludarabine 239Nivolumab 234venetoclax 221Injections 213Docetaxel 211Fluorouracil 206Dexamethasone 188Radiosurgery 182Standard of Care 159Rituximab 159Pemetrexed 156Surgical Procedures, Operative 148atezolizumab 146durvalumab 145Leucovorin 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × icotinib × Clear all
NCT06517953 2024-07-25

IcomBine

Sun Yat-sen University

Phase 2 Recruiting
23 enrolled
Thoracic

Non-small Cell Lung Cancer Metastatic

NCT06041776 2023-09-22

Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations

Betta Pharmaceuticals Co., Ltd.

Phase 3 Recruiting
570 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05104788 2021-11-03

NeoIpower

Peking University Cancer Hospital & Institute

Phase 2 Recruiting
27 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡